Bio-Path HoldingsBPTH
13F holders, Q1 2024 (March 31)10holders
$4.12avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Bio-Path Holdings Inc. (BPTH) in their 13F filings. The largest holders were Vanguard Group Inc. ($56K), BlackRock Inc. ($10K) and Tower Research Capital LLC (TRC) ($8K).
- Company
- Bio-Path Holdings Inc.
- CUSIP
- 09057N409
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 10 holders
| Vanguard Group Inc. | 0.00% | No change | 13,502 | $56K |
| BlackRock Inc. | 0.00% | Reduce -13.0% | 2,381 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +297.8% | 1,934 | $8K |
| UBS Group AG | 0.00% | Add +3.3% | 1,177 | $5K |
| Morgan Stanley | 0.00% | No change | 35 | $144 |
| Group One Trading LLC | 0.00% | Reduce -92.4% | 21 | $89 |
| Bank of America Corp. | 0.00% | Reduce -7.9% | 7 | $29 |
| Wells Fargo & Company | 0.00% | Add +5.3% | 5 | $20 |
| Global Retirement Partners, LLC | 0.00% | Add +15.9% | 4 | $16 |
| Allworth Financial LP | 0.00% | Reduce -86.7% | 1 | $5 |
"% of holder's portfolio" is BPTH's weight in each manager's 13F, not the share of Bio-Path Holdings Inc. the manager owns.